Sign In
Buy MASS
$8.01
+0.370 (+4.84%)
At Close: Jul 31, 2026
908 Devices - Mass Spectrometry, Not For The Masses
09:39am, Sunday, 04'th Apr 2021
908 Devices has seen a soft first quarter as a publicly traded company. This quarter was accompanied by a softer guidance for 2021 as well, despite a big army contract.
908 Devices Reports 50% Top Line Growth, Guides 2021 Up 45%
09:56am, Wednesday, 31'st Mar 2021
908 Devices expects 45% revenue growth this year. About 8% below its IPO price, MASS could be a good bet.
Cathie Wood Is Bullish On 908 Devices. An Analyst Makes A Case For The Stock
04:39am, Wednesday, 31'st Mar 2021
908 Devices Inc (NASDAQ: MASS) is seen as a high-growth life science tools company that analysts at SVB Leerink expect to “outperform” despite conservative 2021 guidance given by its management du
908 Devices' (MASS) CEO Kevin Knopp on Q4 2020 Results - Earnings Call Transcript
02:08pm, Tuesday, 30'th Mar 2021
908 Devices' (MASS) CEO Kevin Knopp on Q4 2020 Results - Earnings Call Transcript
908 Devices Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Revenue Outlook
07:00am, Tuesday, 30'th Mar 2021
2020 Revenue Increased 50% Over Prior Year 2020 Revenue Increased 50% Over Prior Year
908 Devices Awarded Multi-Year $25M Purchase Order to Enable the U.S. Army
06:55am, Tuesday, 30'th Mar 2021
Multi-mission device will support field teams with trace detection point of need analysis Multi-mission device will support field teams with trace detection point of need analysis
U.S. IPO Week Ahead: The Spring IPO Market Starts To Thaw In An 8 IPO Week
08:25am, Saturday, 13'th Mar 2021
The IPO market starts to pick back up with eight IPOs scheduled to raise $2.2 billion in the week ahead. Street research is expected for one company on Sunday, 3/14.
908 Devices Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
05:23pm, Tuesday, 22'nd Dec 2020
BOSTON--(BUSINESS WIRE)--908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced the closing of its upsized initial
908 Devices: Very Interesting Offering
01:50am, Tuesday, 22'nd Dec 2020
908 Devices is a very interesting business with great potential and recent operating momentum. Expectations have risen quite a bit after a big opening day move higher; I still like the long-term poten
